SCHEMBL137100

SCHEMBL137100

Cc1nc2sc3c(c2c(-c2cccc(Cl)c2)c1CCCC(C)C(=O)O)CC=CC=C3

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 2/20 0.39
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15875923 0.88 DHFR (0.40) KMT2A
SCHEMBL135692 0.87 KMT2A (0.46) KMT2A
SCHEMBL15875922 0.81
SCHEMBL137101 0.76 KMT2A (0.35) LTB4RKMT2A
SCHEMBL139225 0.73 KMT2A (0.55) KMT2A
SCHEMBL3475837 0.73 KMT2A (0.50) KMT2A
SCHEMBL142736 0.72 KMT2A (0.58) KMT2A
SCHEMBL134952 0.71 KMT2A (0.51) KMT2A
SCHEMBL140590 0.71 KMT2A (0.50) KMT2A
SCHEMBL15875940 0.71 KMT2A (0.64) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS LTB4R 817/4885KMT2A 2903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.